European Market Report for Colposcopes 2016 - MedCore
Trends in ASP vary extensively across Europe. Due to favorable reimbursement, increased funding and increased interest in colposcopy, the ASPs for Germany, Austria and Switzerland are increasing at a CAGR in the low single digits. These countries are the most likely to purchase higher-end systems with more technical capabilities. Benelux and Scandinavia, on the other hand, have quite stable ASPs as the market in these countries is very mature and will not undergo many changes over the forecast period.
Italy, Spain and Portugal all have a lower ASP relative to the rest of Europe. Due to the less-than-favorable economy in these countries, there has been a significant trend to choose price over quality with cost effective colposcope products from Asia becoming popular.
Most countries will slowly move towards more advanced systems over the forecast period. While the ASP’s are increasing across Europe, the price of individual colposcope products is decreasing slightly. The ASP growth is generated from most countries transitioning towards higher end colposcopes from less expensive lower-end systems.
A colposcope is a low-power stereoscopic, binocular field microscope with a powerful light source used for magnified visual examination of the uterine cervix, vaginal wall and vulva to help in diagnosis.
Colposcopy, a procedure using a colposcope, is performed if there is a positive screening test (ex. positive cytology, abnormal Pap smear etc.). Colposcopy procedures can accurately detect premalignant and malignant lesions. The results of this procedure may show evidence of dysplasia, cancer, HPV or atypical squamous cells of undetermined significance (ASCUS). Biopsies can be taken for further pathological examinations. For collecting evidence from victims of rape and sexual assault, specialized colposcopes equipped with a camera are used.